Today, more than ever, pets with cancer have options
If you were diagnosed with cancer, you’d want to explore every treatment option—and choose the one best for you. Why should it be any different when it comes to your pet? Advances in technology and veterinary oncology have led to a wide variety of treatments, giving pet parents more—and better—choices for cancer care. We’re here to help you find the safest, most effective and least disruptive option possible. After all, the more you know, the more confident you’ll feel in doing what’s right for your pet.
Revolutionizing cancer care for pets with SRS
Until now, pet owners have had extremely limited access to stereotactic radiosurgery (SRS) for dogs, cats or other pets diagnosed with cancer. PetCure Oncology is revolutionizing cancer care for pets with a growing national network of comprehensive cancer care centers that specialize in the delivery of SRS—the first of its kind in the United States.
Through these centers, PetCure Oncology is increasing accessibility to this potentially live-saving treatment for pets across the country and setting the standard for expert, compassionate care in the delivery of veterinary cancer treatment. This means that more pets can benefit from SRS, which in some cases can be delivered with the intent to cure cancer, not merely ease its symptoms.
SRS: Helping us treat the untreatable
Stereotactic radiosurgery (SRS), an advanced form of radiation therapy, offers the chance for a cure—something rarely heard of in pet cancer care. Determined to take the most progressive treatment options in human medicine and make them available in veterinary medicine, PetCure Oncology joined forces with some of the best and brightest minds in cancer care and opened its first center in May of 2015.
Now, for the first time, PetCure Oncology is providing precision cancer care that zeros in and attacks tumors; tumors we couldn’t touch before. Because it offers unprecedented precision, we’re able to destroy the tumor without damaging healthy cells around it. And it’s noninvasive, so the pet patient experiences no discomfort and the risks associated with treatment are minor.
How your pet benefits from SRS
SRS is delivered with the intent to cure the cancer, rather than merely ease its symptoms.
Treatment is noninvasive and nonsurgical, requiring no incisions or sutures.
SRS is performed in just 1 to 3 sessions.
Compared to traditional radiation therapy, SRS provides an 80-95% reduction in both treatment sessions and anesthetic events. This helps optimize the patient’s safety, comfort and convenience.
SRS is an ideal alternative when surgery is difficult or not possible.
In fact, since SRS both shrinks and encapsulates the tumor, it can actually increase the odds of achieving "clean" margins—meaning complete removal of the tumor—if surgery is attempted later on.
Fewer side effects relative to traditional radiation therapy.
SRS is delivered with sub-millimeter precision, maximizing damage to tumorous tissue while minimizing collateral damage to nearby healthy tissue.
More types of cancer can be treated with SRS, including some forms previously considered “untreatable” based on their sensitive locations within the body.
Recovery is fast. Treatments can be performed on consecutive days and pets can usually return to normal activities right after treatment.
Types of pet cancers SRS can treat
SRS can be used to treat a wide range of cancers in pets, including some previously considered “untreatable” due to their sensitive location within the body. Select cancer type or location of tumor to explore SRS treatment options.
- Nasal/paranasal sinus
- Squamous cell carcinoma
- Basal cell
- Salivary gland
- Ceruminous gland
- Bronchogenic/non-small cell lung
- Transitional cell of bladder/prostate/urethra
- Anal gland
- Neuroendocrine carcinoma
- Thymoma (epithelioid)
- Histiocytic sarcoma
- Peripheral nerve sheath tumor/Schwannoma
- Choroid Plexus papilloma
- Multilobular osteochondroma
- Thymoma (lymphoid)
- Multiple Myeloma
- Mast Cell Tumor
Head and neck
- Oral melanomas
- Squamous cell carcinomas
- Acanthomatous amelioblastomas
- Nasal tumors
- Pituitary tumors
- Soft-tissue sarcomas
- Infiltrative lipomas
- Mast cell tumors
Pelvic canal tumors
- Anal gland adenocarcinomas
- Prostatic tumors